A Study of PRT-201 Administered After Arteriovenous Graft (AVG) Creation in Patients With Chronic Kidney Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Chronic Kidney Disease
Interventions
DRUG

PRT-201

Applied topically during surgery.

DRUG

Placebo

Applied topically during surgery

Trial Locations (16)

10065

Weill Cornell Medical College, New York

20010

Washington Hospital/Medstar Research, Washington D.C.

23507

Sentara Vascular Specialists, Norfolk

27710

Duke University Medical Center, Durham

29615

Greenville Memorial Hospital, Greenville

40202

University of Louisville, Louisville

45267

University of Cincinnati, Cincinnati

46202

Indiana University/Purdue University, Indianapolis

46804

Indiana/Ohio Heart, Fort Wayne

70809

Vascular Specialty Center, Baton Rouge

77030

The Methodist Hospital, Houston

78205

Peripheral Vascular Associates, San Antonio

92123

California Institute of Renal Research, San Diego

93710

Ladenheim Dialysis Access Center, Fresno

02115

Brigham & Women's Hospital, Boston

01655

University of Massachusetts, Worcester

Sponsors
All Listed Sponsors
lead

Proteon Therapeutics

INDUSTRY